Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations

Authors:

Abstract
No abstract available
Funding Information
  • The Swedish Physicians Against AIDS Research Foundation (FOa2016-0009)
  • Göteborg Medical Society (16/596971)

This publication has 22 references indexed in Scilit: